Detalhe da pesquisa
1.
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
J Infect Dis
; 224(4): 565-574, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398242
2.
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Nat Commun
; 13(1): 383, 2022 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046397
3.
A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.
ISBT Sci Ser
; 16(4): 276-283, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226835